Sound waves take on pancreatic cancer: new trial tests focused ultrasound
NCT ID NCT07325214
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This clinical trial tests whether adding focused ultrasound (IMD10) to standard chemotherapy can help people with borderline resectable or locally advanced pancreatic cancer. The study will enroll 136 adults aged 18-85 with confirmed pancreatic ductal adenocarcinoma. Half will get chemotherapy alone, the other half chemotherapy plus focused ultrasound, and researchers will track overall survival to see if the combination works better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
focused ultrasound (IMD10 device) plus chemotherapy (irinotecan, oxaliplatin, 5-FU, leucovorin)
What this could lead to
If it works, this could offer a new way to shrink pancreatic tumors, potentially making more patients eligible for surgery and improving survival.
What could go wrong
This is a relatively small, early-stage trial (136 people) and focused ultrasound for pancreatic cancer is still experimental. It may not improve outcomes or could have unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact
-
Seoul National University Bundang Hospital,
Gyeonggi-do, 13620, South Korea
Contact
-
Seoul National University Hospital
Seoul, 03080, South Korea
Contact
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Contact
-
University of Virginia Medical Center
Charlottesville, Virginia, 22908, United States
Contact